UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000024091
Receipt No. R000027730
Scientific Title Phase II study of capecitabine and temozolomide (CAPTEM)in patients with unresectable neuroendocrien tumor
Date of disclosure of the study information 2016/09/17
Last modified on 2016/09/17 10:35:12

No. Disposal Last modified on Item of update
1 Insert 2016/09/17 10:24:39
2 Update 2016/09/17 10:35:12 Key exclusion criteria


Contact us.